About Velesco Pharma
Velesco Pharma is a company based in Plymouth (United States) founded in 2008 was acquired by Pace Analytical in October 2021. Velesco Pharma operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
- Headquarter Plymouth, United States
- SectorsHealthcare
- Email••••••••
- Website velescopharma.com
- Social LinkedIn X Facebook
- Acquired by Pace Analytical (Oct 2021)
- Investors
- Acquired byPace Analytical
(Oct 2021)
Investors in Velesco Pharma
Velesco Pharma has secured backing from 1 investor. Prominent investors backing the company include Pace Analytical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of analytical and environmental testing services, and life sciences CDMO/CRO services | 1978 | pacelabs.com | Minneapolis, United States |
Investor details for Velesco Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Velesco Pharma
2 dated milestones of Velesco Pharma across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Velesco Pharma is founded.
- Exit Acquired by Pace Analytical.
Competitors of Velesco Pharma
Velesco Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| biosynth.com | 1966 | Thal, Switzerland | – | – | Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics. |
Detailed competitors of Velesco Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Velesco Pharma
Websites that share an audience with Velesco Pharma (velescopharma.com).
Websites whose visitors overlap most with Velesco Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
christophermarrs.tripod.com | christophermarrs.tripod.com | 100% | – | – | – |
| irisys.com | 99% | – | – | View details | |
| pharmatek.com | 99% | – | – | View details | |
| corerxpharma.com | 98% | – | – | View details | |
| dptlabs.com | 98% | 1.5K | #8,022,749 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Velesco Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Velesco Pharma
Complete news archive for Velesco Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Velesco Pharma
10 companies that operate in the same segment as Velesco Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Velesco Pharma
Velesco Pharma was founded in 2008.
Velesco Pharma is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Velesco is a CMC contract research organization, founded and staffed by pharmaceutical scientists from Pfizers former Michigan RD campus. Their team has experience with more than 200 drug development programs. Their service offering includes the following - Analytical Method Development, Drug Formulation, GMP Clinical Supplies for phase 1 and 2 clinical trials, offering a full range of non-sterile dosage forms and Pharmaceutical Consulting such as project and clinical supply chain management; CMC IND submission; due diligence; patent litigation support; drug product and formulation development; facility and equipment validation; regulatory support; and GMP documentation. The Velesco team offers personalized project management, state-of-the-art facilities and an experienced laboratory staff leading to comprehensive research relationships.
Velesco Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Velesco Pharma has 1 investor. Key investors include Pace Analytical.
Yes. Velesco Pharma was acquired by Pace Analytical in October 2021.